Welcome! This blog contains research & information on lifestyle, nutrition and health for those with MS, as well as continuing information on the understanding of CCSVI and cerebral hypoperfusion. This blog is informative only--all medical decisions should be discussed with your own physicians.

The posts are searchable---simply type in your topic of interest in the search box at the top left.

Almost all of MS research is initiated and funded by pharmaceutical companies. This maintains the EAE mouse model and the immune paradigm of MS, and continues the 20 billion dollar a year MS treatment industry. But as we learn more about slowed blood flow, gray matter atrophy, and environmental links to MS progression and disability--all things the current drugs do not address--we're discovering more about how to help those with MS.

To learn how this journey began, read my first post from August, 2009. Be well! Joan

Saturday, September 1, 2012


Safety and Efficacy of Venoplasty for CCSVI-PUBLISHED RESEARCH

September 1, 2012 at 8:28am

Here is the list of published research on venoplasty for CCSVI.  As the stack of publications grows, it is my hope that the media and medical establishment will refer to these studies, and the correct medical terms.  This is no longer "controversial liberation therapy"

This is venoplasty, or endovascular treatment, for CCSVI.

 Clinical Improvement after Extracranial Venoplasty in Multiple Sclerosis

Safety of endovascular treatment of chronic cerebrospinal venous insufficiency: a report of 240 patients with multiple sclerosis.


Catheter venography and endovascular treatment of chronic cerebrospinal venous insufficiency.

Reported outcomes after the endovascular treatment of chronic cerebrospinal venous insufficiency.

Safety of outpatient endovascular treatment of the internal jugular and azygos veins for chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis: A retrospective analysis

Safety profile of endovascular treatment for chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.

Endovascular treatment for chronic cerebrospinal venous insufficiency

The Hemodynamic Impact of Balloon Angioplasty in Multiple Sclerosis Patients with Chronic Cerebrospinal Venous Insufficiency

Evolution in quality of life and epidemiological impact after endovascular treatment of chronic cerebro-spinal venous insufficiency in patients with multiple sclerosis.

Venous angioplasty in multiple sclerosis: neurological outcome at two years in a cohort of relapsing-remitting patients 

Endovascular treatment of patients with chronic cerebrospinal venous insufficiency and multiple sclerosis.

Venous angioplasty in patients with multiple sclerosis: results of a pilot study.

Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe?

For all the published research on CCSVI, please visit (and support) CCSVI Alliance

thanks,
Joan

No comments:

Post a Comment